Palisade Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.46

+0.03 (+2.10%)

As of Oct 3, 2:16 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +201.4% upside

Low Target $2.36

Average Target $4.40

High Target $4.89

Current Price $1.46

Current
$1.46

Target
$4.40

$2.36 $4.40 avg $4.89

Scenario Analysis

Bear Case

$2.36

61.6%

Low target

Base Case

$4.40

+201.4%

Avg target

Bull Case

$4.89

+234.9%

High target

Risk/Reward

3.8x

Highly favorable

Price in Context

52-Week High

$2.86

-48.9% from high

52-Week Low

$0.96

+52.1% from low

Target vs 52W High

$4.40

+54.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.0%
AMGN Amgen Inc	Hold	43	47%	$190.87	-52.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+150.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-13.2%
MRNA Moderna Inc	Hold	30	37%	$149.45	-21.3%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.8%